Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2025-12-25 @ 4:34 AM
NCT ID:
NCT00391118
Eligibility Criteria:
Inclusion Criteria:
* Participants must have specific stages of disease, known as Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stages IIB, IIC, III or IV
* Organ functions (blood, renal, liver, cardiac) must meet specific requirements.
* Participants who could become pregnant must take care not to become pregnant during the study participation and for 6 months after study discontinuation
* Participants must give written consent for study participation.
Exclusion Criteria:
* Participants received any experimental drug within the last 30 days.
* Participants received any prior chemotherapy or other drug therapy for the current disease.
* Participants receive any other treatment for the cancer during study participation.
* Participants are unable to discontinue concurrent administration of carbamazepine, phenobarbital, or phenytoin.
* Participants are pregnant, breast feeding, or not using adequate contraceptive methods to prevent pregnancy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00391118
Study Brief:
Protocol Section:
NCT00391118